GH Research PLC (GHRS)
NASDAQ·Healthcare·Biotechnology
$27.16
-0.07%
Mkt Cap $1.94B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
Implied Upside
+52.8%
Consensus $41.50 vs current $27.16
NASDAQ·Healthcare·Biotechnology
$27.16
-0.07%
Mkt Cap $1.94B
Buy
5
Hold
0
Sell
0
Price Target (13 analysts)
$41.50
Range $32.00 – $65.00
+52.8%
Consensus $41.50 vs current $27.16